3The International Menopause Society. Updated 2013 International Men- opause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health [ J ]. Climacteric,2013,16 ( 3 ) : 316 -337.
5Villiers TJ, Pines A, Panay N, et al. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health[J]. Climacteric, 2013, 16 (3): 316-337.
6Sturdec DW, Pines A, Archer DF, et al. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health[J]. Climacteric, 2011,14:302-320.
7Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progesterone in healthy post-menopausal women [J].JAMA, 2002, 288 (3):321-333.
8Rossouw JE, al. Postmenopausal cardiovascular disease [J]. JAMA, 2007, 297 Prentice RL, Manson JE, et hormone therapy and risk of by age and years since menopause (13) : 1465-1477.
9Panay N, Fenton h. h global consensus statement on menopause hormone therapy-aim s, aspirations and action points[J]. Climacteric, 2013, 16:201-202.
10Santen RJ, Allred DC, Ardoin SP, et al.Postmenopausal hormone therapy: an Endocrine Society scientific statement[J]. J Clin Endocrinol Metab2010, 95 (7 Suppl 1): S1-66.
